4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-004422
Chief Business Officer sold 100,000 shares at an average $4.50 ($450,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 2020-01-13 | Sale | −50,000 | $4.00 | $200,000 | 0 | D |
| TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 2020-01-13 | Sale | −50,000 | $5.00 | $250,000 | 0 | D |
| Open-market sales · 100,000 sh · avg $4.50 · $450,000 | |||||||
Loading xslF345X03/a4.xml…